Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DR26FCTB2
Awardee
Awarding agency
Obligated
$9,475

Award facts

Contract value 100% obligated
$9,475.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $9,475.32 delivery order to DMS Pharmaceutical Group Inc. on June 26, 2026, for Xolair 150 mg/ml syringe under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical is a woman-owned small business.

PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order has an ultimate completion date of July 20, 2026.

Quick answers

Who was awarded contract SPE2DR26FCTB2?

SPE2DR26FCTB2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 26, 2026.

How much is contract SPE2DR26FCTB2 worth?

The government has obligated $9,475 on SPE2DR26FCTB2.

Is contract SPE2DR26FCTB2 an order under another contract?

Yes. SPE2DR26FCTB2 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.

Was contract SPE2DR26FCTB2 competed?

The extent of competition for SPE2DR26FCTB2 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login